Table 1. Characteristics of the participants.
| Characteristics | Values (n=30) |
|---|---|
| Age, median [range], years | 55 [49–62] |
| Sex (male/female) | 25/5 |
| HBsAg (positive/negative) | 26/4 |
| Tumor size, mean ± SD, cm | 7.2±2.6 |
| No. of lesions (1/≥2/≥3) | 24/6 |
| Type of portal vein thrombosis (Vp1/Vp2/Vp3)† | 7/11/12 |
| α-fetoprotein, median (IQR), ng/mL | 179.5 (15.9–3,460.5) |
| Protein induced by vitamin K absence, median (IQR), mAU/mL | 978.5 (212.0–8,113.0) |
| Total bilirubin, mean ± SD, μmol/L | 13.9±6.0 |
| Alanine transaminase, mean ± SD, U/L | 41.0±24.7 |
| Albumin, mean ± SD, g/L | 43.8±3.8 |
| γ-glutamyl transferase, mean ± SD, U/L | 96.2±63.1 |
| International normalized ratio, mean ± SD | 1.0±0.1 |
| Hemoglobin, mean ± SD, g/L | 145.4±16.3 |
| Platelets, mean ± SD, ×109/L | 154.0±66.1 |
| Leukocytes, mean ± SD, ×109/L | 4.9±1.9 |
†, based on the Liver Cancer Study Group of Japan (LCSGJ) classification. IQR, interquartile range; SD, standard deviation.